PubMed ID: 37220815 Author(s): Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Investigator Group. SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion. …
WRC
Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes.
PubMed ID: 37406846 Author(s): Jabs DA, Sugar EA, Burke AE, Altaweel MM, Dunn JP, Gangaputra S, Kempen JH, Pepple KL, Stawell RJ, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. …
Association of macular pigment optical density with retinal layer thicknesses in eyes with and without manifest primary open-angle glaucoma.
PubMed ID: 37890895 Author(s): Lawler T, Mares JA, Liu Z, Thuruthumaly C, Etheridge T, Vajaranant TS, Domalpally A, Hammond BR, Wallace RB, Tinker LF, Nalbandyan M, Klein BEK, Liu Y; Carotenoids in Age-Related Eye Disease …
Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results.
PubMed ID: 37318415 Author(s): Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee:; Acharya NR, Vitale AT, Sugar EA, Holbrook JT, Burke AE, Thorne JE, Altaweel MM, Kempen JH, Jabs DA. Intravitreal Therapy for …
Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular Degeneration.
PubMed ID: 37086257 Author(s): Blodi BA, Domalpally A, Corkery E, Osborne A, Blotner S, Grzeschik SM, Gune S. Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular Degeneration. …
Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply.
PubMed ID: 37227711 Author(s): Domalpally A, Pan Q, Chew EY. Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply. JAMA Ophthalmol. 2023 Jul 1;141(7):697. doi: 10.1001/jamaophthalmol.2023.1892. No …
Coats’ Disease in a Patient With Cornelia de Lange Syndrome: Management With Laser and Bevacizumab.
PubMed ID: 37478198 Author(s): Elwood KF, Fleege SM, Bradfield YS, Altaweel MM. Coats’ Disease in a Patient With Cornelia de Lange Syndrome: Management With Laser and Bevacizumab. J Pediatr Ophthalmol Strabismus. 2023 Jul-Aug;60(4):e45-e48. doi: 10.3928/01913913-20230619-03. …
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.
PubMed ID: 37166820 Author(s): Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group. Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein …
High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21.
PubMed ID: 37367722 Author(s): Mehta N, Patil S, Modi V, Vardi R, Liu K, Singh RP, Sarraf D, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, Modi Y. High Variation in Inner Retinal …